Increased cerebrospinal fluid glutamine levels in depressed patients

被引:182
作者
Levine, J
Panchalingam, K
Rapoport, A
Gershon, S
McClure, RJ
Pettegrew, JW
机构
[1] Univ Pittsburgh, Sch Med, Neurophys Lab, Dept Psychiat, Pittsburgh, PA 15260 USA
[2] Ben Gurion Univ Negev, Fac Hlth Sci, Beersheva Mental Hlth Ctr, Beer Sheva, Israel
[3] Volfson Hosp, Dept Neurol, Holon, Israel
关键词
major depression; H-1; MRS; glutamine; creatine; beta-hydroxybutyrate;
D O I
10.1016/S0006-3223(99)00284-X
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: There is increasing evidence far an association between alterations of brain glutamatergic neuro-transmission? and the pathophysiology of affective disorders. Methods: We studied the association between cerebrospinal fluid (CSF) metabolites, including glutamine, in unipolar and bipolar depressed patients versus control subjects using a proton magnetic resonance spectroscopy technique. Cerebrospinal fluid samples were obtained from 18 hospitalized patients with acute unmedicated severe depression without medical problems and compared with those of 22 control subjects. Results: Compared with the control group, the depressed patient group had significantly higher CSF glutamine concentrations, which correlated positively with CSF magnesium levels. Conclusions: These findings suggest art abnormality of the brain glial-neuronal glutamine/glutamate cycle associated with N-methyl-D-aspartate receptor systems in patients with depression. (C) 2000 Society of Biological Psychiatry.
引用
收藏
页码:586 / 593
页数:8
相关论文
共 44 条
[1]   CREATININE AND CREATINE IN CSF - INDEXES OF BRAIN ENERGY-METABOLISM IN DEPRESSION [J].
AGREN, H ;
NIKLASSON, F .
JOURNAL OF NEURAL TRANSMISSION, 1988, 74 (01) :55-59
[2]   Plasma concentrations of excitatory amino acids, serine, glycine, taurine and histidine in major depression [J].
Altamura, C ;
Maes, M ;
Dai, J ;
Meltzer, HY .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1995, 5 :71-75
[3]  
ALTAMURA CA, 1993, AM J PSYCHIAT, V150, P1731
[4]  
*AM PSYCH ASS, 1987, DIAGN STAT MAN PSYCH
[5]  
BARKAI AI, 1978, BIOL PSYCHIAT, V13, P65
[6]  
CHAUHAN S, 1980, NUTR METAB, V24, P43
[7]  
DUBOVSKY SL, 1992, AM J PSYCHIAT, V149, P118
[8]  
GERNER RH, 1981, AM J PSYCHIAT, V138, P1098
[9]  
Hamilton M., 1967, British Journal of Social and Clinical Psychology, V6, P278
[10]  
HAUANG NU, 1997, ANTIDEPRESSANTS NEW, P125